Position in XENE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,584,968
-$426,471 QoQ
Shares Held
130,438
-27.0% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 99.95246783912664.ToString("F0")%
Shared 0.ToString("F0")%
None 0.04753216087336512.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NEUBERGER BERMAN GROUP LLC holds $1,136,881,142 across 81 Biotechnology names. XENE ranks #16 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,129 | $330,016,949 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,522 | $246,276,633 | |
| 3 | TECH |
BIO-TECHNE Corp
|
3,340,837 | $174,592,141 | |
| 4 | CAI |
Caris Life Sciences, Inc.
|
3,590,586 | $64,199,677 | |
| 5 | INSM |
INSMED Inc
|
270,700 | $44,264,863 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
443,272 | $33,285,294 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
93,496 | $30,935,021 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
480,740 | $25,344,612 |
All Filings in XENE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,584,968 | 130,438 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $8,011,439 | 178,747 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,920,012 | 172,354 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,613,963 | 147,411 | Shares | Defined | 2025-08-25 | |
| 2025-03-31 | $1,504,783 | 44,852 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,644,071 | 92,961 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||